Hematopoietic Stem Cell Transplantation in Children with Refractory Cytopenia of Childhood: Single-Center Experience Using High-Dose Cytarabine Containing Myeloablative and Aplastic Anemia Oriented Reduced-Intensity Conditioning Regimens

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 3, 2015, Pages 565-569

  Inagaki, Jiro ^a   Fukano, Reiji ^a   Kurauchi, Koichiro ^a   Noguchi, Maiko ^a   Tanioka, Shinji ^a   Okamura, Jun ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Hematopoietic stem cell transplantation; Reduced intensity conditioning; Refractory cytopenia of childhood

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; MELPHALAN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CYTOPENIA; DISEASE COURSE; DRUG MEGADOSE; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MONOSOMY 7; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PROBABILITY; RADIATION DOSE; REDUCED INTENSITY CONDITIONING; REFRACTORY CYTOPENIA OF CHILDHOOD; RELAPSE; TREATMENT OUTCOME; TRISOMY 8; WHOLE BODY RADIATION; ANEMIA, APLASTIC; CLINICAL TRIAL; DISEASE FREE SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; MYELODYSPLASTIC SYNDROMES; PRESCHOOL CHILD; PROCEDURES; SURVIVAL RATE;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYELODYSPLASTIC SYNDROMES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING;

EID: 84922821399     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.12.003     Document Type: Article

References (20)

1. Niemeyer C.M., Kratz C.P. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol 2008, 140:610-624.
2. Niemeyer C.M., Baumann I. Myelodysplastic syndrome in children and adolescents. Semin Hematol 2008, 45:60-70.
3. Kardos G., Baumann I., Passmore S.J., et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003, 102:1997-2003.
4. Baumann I., Niemeyer C.M., Benett J. Childhood myelodysplastic syndrome. WHO classification of tumors of haematopoietic and lymphoid tissues 2008, 104-107. IARC Press, Lyon. S. Swerdlow, E. Campo, N. Harris (Eds.).
5. Yusuf U., Frangoul H.A., Gooley T.A., et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant 2004, 33:805-814.
6. Woodard P., Carpenter P.A., Davies S.M., et al. Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. Biol Blood Marrow Transplant 2011, 17:723-728.
7. Strahm B., Nöllke P., Zecca M., et al. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia 2011, 25:455-462.
8. Smith A.R., Christiansen E.C., Wagner J.E., et al. Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS. Pediatr Blood Cancer 2013, 60:705-710.
9. Madureira A.B., Eapen M., Locatelli F., et al. Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. Leukemia 2011, 25:449-454.
10. Parikh S.H., Mendizabal A., Martin P.L., et al. Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience. Biol Blood Marrow Transplant 2009, 15:948-955.
11. Strahm B., Locatelli F., Bader P., et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant 2007, 40:329-333.
12. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982, 51:189-199.
13. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. JClin Oncol 1999, 17:3835-3849.
14. Hasle H., Niemeyer C.M., Chessells J.M., et al. Apediatric approach to the WHO classification of myelodysplastic and myeloproliferative disease. Leukemia 2003, 17:277-282.
15. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
16. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
17. Yoshimi A., van den Heuvel-Eibrink M.M., Baumann I., et al. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood. Haematologica 2014, 99:656-663.
18. Hasegawa D., Chen X., Hirabayashi S., et al. Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification. Br J Haematol 2014, 166:758-766.
19. Barrett J., Saunthararajah Y., Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?. Semin Hematol 2000, 37:15-29.
20. Sugawara T., Endo K., Shishido T., et al. Tcell-mediated inhibition of erythropoiesis in myelodysplastic syndromes. Am J Hematol 1992, 41:304-305.